What are tumour agnostic cancer treatments and which biomarkers do they target?

Join Prof. David Hong (Medical Oncologist at MD Anderson Cancer Center, Houston, Texas, United States) and Dr Tracy L Stockley (Pathologist and Geneticist at University Health Network, Toronto, Canada) as they deep dive into the topic of tumour agnostic therapies in this video podcast.

As the conversation unfolds, the precision oncology experts explore the issues and challenges associated with developing tumour agnostic therapies and discuss how these treatments differ from others.

Watch and listen to deepen your understanding of:
• Biomarker targets associated with tumour agnostic therapies
• Which tumours carry these gene alterations
• Appropriate genetic testing strategies to detect these biomarkers


Prefer to listen on the go?
Get the podcast audio of the experts in conversation and download the full transcript on the COR2ED website: [ Ссылка ]

Or listen on your usual podcast platform:
Spotify: [ Ссылка ]
Apple: [ Ссылка ]

Find out more about the experts:
Prof. David Hong ([ Ссылка ])
Dr Tracy L Stockley ([ Ссылка ])

The medical experts in this podcast are expressing their own views and not those of COR2ED, supporters, or their institution. This podcast is supported by an Independent Medical Education Grant from Bayer and is developed by cor2ed.com.

свернуть